Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.

Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, García E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, Maestro de la Calle G, Manzur A, Marin JI, Márquez-Gómez I, Martín-Dávila P, Mikulska M, Montejo JM, Montero M, Morales HMP, Morales I, Novo A, Oltolini C, Peghin M, Del Pozo JL, Puerta-Alcalde P, Ruiz-Camps I, Sipahi OR, Tilley R, Yáñez L, Gomes MZR, Carratalà J; IRONIC study group.

BMJ Open. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744.

2.

Laparoscopic celiac plexus ganglioneuroma resection: A video case report.

Hemmati P, Ghanem O, Bingener J.

World J Gastrointest Surg. 2019 Mar 27;11(3):191-197. doi: 10.4240/wjgs.v11.i3.191.

3.

One Hundred and Counting: Dr. Dwight C. McGoon's Enduring Legacy.

Hemmati P, Arghami A, Dearani JA, Daly RC, Schaff HV.

Ann Thorac Surg. 2019 Apr 12. pii: S0003-4975(19)30527-2. doi: 10.1016/j.athoracsur.2019.02.073. [Epub ahead of print]

PMID:
30986417
4.

Enhancing surveillance for early detection of Zika virus infection: strategies for the countries of Eastern Mediterranean Region.

Obtel M, Malik MR, Nguyen TMN, Buliva E, Elkhobby A, Salim SA, Ghosn N, Hemmati P, Thuan V, Mala P.

East Mediterr Health J. 2019 Mar 19;25(1):58-65. doi: 10.26719/emhj.18.011.

5.

Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy.

Waldhüter N, Köhler W, Hemmati PG, Jehn C, Peceny R, Vuong GL, Arnold R, Kühl JS.

J Inherit Metab Dis. 2019 Mar;42(2):313-324. doi: 10.1002/jimd.12044. Epub 2019 Feb 11.

PMID:
30746707
6.

Early Outcomes of Cardiac Surgery in Patients with Noonan Syndrome.

Hemmati P, Dearani JA, Daly RC, King KS, Ammash NM, Cetta F, Schaff HV.

Semin Thorac Cardiovasc Surg. 2018 Dec 18. pii: S1043-0679(18)30374-5. doi: 10.1053/j.semtcvs.2018.12.004. [Epub ahead of print]

PMID:
30576779
7.

Preventing pediatric cardiothoracic trauma: Role of policy and legislation.

Mylonas KS, Hemmati P, Tsilimigras DI, Texakalidis P, Economopoulos KP.

World J Cardiol. 2018 Jul 26;10(7):49-51. doi: 10.4330/wjc.v10.i7.49.

8.

BCR-ABL+ acute myeloid leukemia: are we always dealing with a high-risk disease?

Neuendorff NR, Hemmati P, Arnold R, Ihlow J, Dörken B, Müller-Tidow C, Westermann J.

Blood Adv. 2018 Jun 26;2(12):1409-1411. doi: 10.1182/bloodadvances.2018015594. No abstract available.

9.

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lübbert M, Rummelt C, Bertz H, Wäsch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rösler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stölzel F, Ordemann R, Müller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kröger N, Ayuk F, Vago L, Ciceri F, Müller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dörfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Börries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K, Shah O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socié G, Caligiuri MA, Ruggiero E, Bonini C, Häcker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R.

Nat Med. 2018 Apr 10;24(4):526. doi: 10.1038/nm0418-526c.

PMID:
29634689
10.

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.

Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C.

Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9.

PMID:
29632329
11.

Pediatric Cardiac Trauma in the United States: A Systematic Review.

Mylonas KS, Tsilimigras DI, Texakalidis P, Hemmati P, Schizas D, Economopoulos KP.

World J Pediatr Congenit Heart Surg. 2018 Mar;9(2):214-223. doi: 10.1177/2150135117747488. Review.

PMID:
29544413
12.

Influenza Vaccination in Identified People Living with HIV/AIDS and Health Care Providers of Triangular Clinics in Iran, 2015-2016.

Gouya MM, Tayeri K, Akbari H, Rezaei F, Hemmati P, Soroush M.

Iran J Public Health. 2018 Feb;47(2):297-298. No abstract available.

13.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lübbert M, Rummelt C, Bertz H, Wäsch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rösler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stölzel F, Ordemann R, Müller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kröger N, Ayuk F, Vago L, Ciceri F, Müller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dörfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Börries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K, Shah O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socié G, Caligiuri MA, Ruggiero E, Bonini C, Häcker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R.

Nat Med. 2018 Mar;24(3):282-291. doi: 10.1038/nm.4484. Epub 2018 Feb 12. Erratum in: Nat Med. 2018 Apr 10;24(4):526.

14.

Influenza virus but not MERS coronavirus circulation in Iran, 2013-2016: Comparison between pilgrims and general population.

Yavarian J, Shafiei Jandaghi NZ, Naseri M, Hemmati P, Dadras M, Gouya MM, Mokhtari Azad T.

Travel Med Infect Dis. 2018 Jan - Feb;21:51-55. doi: 10.1016/j.tmaid.2017.10.007. Epub 2017 Oct 12.

PMID:
29031546
15.

Contemporary Techniques of Pericardiectomy for Pericardial Disease.

Hemmati P, Greason KL, Schaff HV.

Cardiol Clin. 2017 Nov;35(4):559-566. doi: 10.1016/j.ccl.2017.07.009. Review.

PMID:
29025547
16.

Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.

Hemmati PG, Pfeifer K, Vuong LG, Jehn CF, Terwey TH, le Coutre P, Dörken B, Arnold R.

Bone Marrow Transplant. 2018 Jan;53(1):101-103. doi: 10.1038/bmt.2017.215. Epub 2017 Oct 9. No abstract available.

PMID:
28991253
17.

Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.

Pulewka K, Wolff D, Herzberg PY, Greinix H, Heussner P, Mumm FHA, von Harsdorf S, Rieger K, Hemmati P, Hochhaus A, Hilgendorf I.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1613-1619. doi: 10.1007/s00432-017-2424-4. Epub 2017 Apr 19.

PMID:
28424902
18.

Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy.

Kühl JS, Suarez F, Gillett GT, Hemmati PG, Snowden JA, Stadler M, Vuong GL, Aubourg P, Köhler W, Arnold R.

Brain. 2017 Apr 1;140(4):953-966. doi: 10.1093/brain/awx016.

19.

Initial Field Test of a Cloud-Based Cardiac Auscultation System to Determine Murmur Etiology in Rural China.

Pyles L, Hemmati P, Pan J, Yu X, Liu K, Wang J, Tsakistos A, Zheleva B, Shao W, Ni Q.

Pediatr Cardiol. 2017 Apr;38(4):656-662. doi: 10.1007/s00246-016-1563-8. Epub 2017 Feb 2.

PMID:
28150025
20.

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.

Hemmati PG, Vuong LG, Terwey TH, Jehn CF, le Coutre P, Penack O, Na IK, Dörken B, Arnold R.

Eur J Haematol. 2017 Feb;98(2):160-168. doi: 10.1111/ejh.12815. Epub 2016 Oct 22.

PMID:
27706846
21.

Estimation of influenza and severe acute respiratory illness incidence (burden) in three provinces of the Islamic Republic of Iran, 2012 and 2013.

Gouya M, Rezaei F, Haghdoost A, Nabavi M, Farahi KS, Mostafavi E, Azad TM, Akbari H, Soroush M, Riazi H, Bitaraf E, Dadras MN, Barati H, Shakoori H, Bathaei J, Rezvani M, Hemmati P.

East Mediterr Health J. 2016 Oct 2;22(7):432-439.

22.

Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.

Jehn CF, Hemmati P, Lehenbauer-Dehm S, Kümmel S, Flath B, Schmid P.

Clin Breast Cancer. 2016 Dec;16(6):514-519. doi: 10.1016/j.clbc.2016.06.001. Epub 2016 Jun 14.

PMID:
27395417
23.

A Rare Case of Acute Myeloid Leukemia with a t(2;3) Chromosomal Translocation Characterized by Thrombophilia and Chemoresistance.

Bozzetti C, Türkmen S, Richter U, Fransecky L, Bal G, Schulz CO, Hemmati P, Arnold R, Riess H, le Coutre P.

J Clin Exp Hematop. 2016;56(1):64-8. doi: 10.3960/jslrt.56.64.

24.

Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.

Erdmann JH, Graf B, Blau IW, Fischer F, Timm G, Hemmati P, Arnold R, Penack O.

Transpl Infect Dis. 2016 Jun;18(3):354-60. doi: 10.1111/tid.12529. Epub 2016 May 17.

PMID:
26998687
25.

Frequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation.

Massenkeil G, Zschieschang P, Thiel G, Hemmati PG, Budach V, Dörken B, Pross J, Arnold R.

Radiat Oncol. 2015 Dec 30;10:266. doi: 10.1186/s13014-015-0576-4.

26.

Apoptosis Susceptibility Prolongs the Lack of Memory B Cells in Acute Leukemic Patients After Allogeneic Hematopoietic Stem Cell Transplantation.

Mensen A, Oh Y, Becker SC, Hemmati PG, Jehn C, Westermann J, Szyska M, Göldner H, Dörken B, Scheibenbogen C, Arnold R, Na IK.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1895-906. doi: 10.1016/j.bbmt.2015.08.008. Epub 2015 Aug 10.

27.

Assessing Bone Mineral Density Following Acute Hip Fractures: The Role of Computed Tomography Attenuation.

Emohare O, Wiggin M, Hemmati P, Switzer J.

Geriatr Orthop Surg Rehabil. 2015 Mar;6(1):16-21. doi: 10.1177/2151458514560215. Review.

28.

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.

Hemmati PG, Terwey TH, Na IK, Jehn CF, le Coutre P, Vuong LG, Dörken B, Arnold R.

Eur J Haematol. 2015 Dec;95(6):498-506. doi: 10.1111/ejh.12522. Epub 2015 Mar 24.

PMID:
25598394
29.

BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.

Neuendorff NR, Schwarz M, Hemmati P, Türkmen S, Bommer C, Burmeister T, Dörken B, le Coutre P, Arnold R, Westermann J.

Acta Haematol. 2015;133(2):237-41. doi: 10.1159/000368176. Epub 2014 Nov 12.

PMID:
25401297
30.

Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.

Kaeda J, Ringel F, Oberender C, Mills K, Quintarelli C, Pane F, Koschmieder S, Slany R, Schwarzer R, Saglio G, Hemmati P, van Lessen A, Amini L, Gresse M, Vagge E, Burmeister T, Serra A, Carson A, Schwarz M, Westermann J, Jundt F, Dörken B, le Coutre P.

Leuk Lymphoma. 2015 Jul;56(7):2105-13. doi: 10.3109/10428194.2014.981175. Epub 2015 Jan 23.

PMID:
25363400
31.

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.

Hemmati PG, Terwey TH, Na IK, le Coutre P, Jehn CF, Vuong LG, Dörken B, Arnold R.

Eur J Haematol. 2015 May;94(5):431-8. doi: 10.1111/ejh.12449. Epub 2014 Oct 11.

PMID:
25220715
32.

Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case report.

Ostendorf BN, Jehn CF, Vuong LG, Nogai H, Hemmati PG, Gebauer B, Penack O, Blau IW, Anagnostopoulos I, Arnold R.

Springerplus. 2014 Jun 2;3:278. doi: 10.1186/2193-1801-3-278. eCollection 2014.

33.

Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation.

Ostendorf BN, Terwey TH, Hemmati PG, Böhmer D, Pleyer U, Arnold R.

Eur J Haematol. 2015 Jul;95(1):90-2. doi: 10.1111/ejh.12400. Epub 2014 Jul 2.

PMID:
24935205
34.

Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.

Terwey TH, Hemmati PG, Nagy M, Pfeifer H, Gökbuget N, Brüggemann M, Le Duc TM, le Coutre P, Dörken B, Arnold R.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1522-9. doi: 10.1016/j.bbmt.2014.05.026. Epub 2014 Jun 4.

35.

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.

Mensen A, Jöhrens K, Anagnostopoulos I, Demski S, Oey M, Stroux A, Hemmati P, Westermann J, Blau O, Wittenbecher F, Movassaghi K, Szyska M, Thomas S, Dörken B, Scheibenbogen C, Arnold R, Na IK.

Blood. 2014 Aug 7;124(6):963-72. doi: 10.1182/blood-2013-11-539031. Epub 2014 May 15.

36.

Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.

Hemmati PG, Schulze-Luckow A, Terwey TH, le Coutre P, Vuong LG, Dörken B, Arnold R.

Eur J Haematol. 2014 Feb;92(2):102-10. doi: 10.1111/ejh.12216. Epub 2013 Nov 21.

PMID:
24138573
37.

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.

Gillissen B, Richter A, Richter A, Overkamp T, Essmann F, Hemmati PG, Preissner R, Belka C, Daniel PT.

Cell Death Dis. 2013 May 23;4:e643. doi: 10.1038/cddis.2013.67.

38.

p14ARF induces apoptosis via an entirely caspase-3-dependent mitochondrial amplification loop.

Milojkovic A, Hemmati PG, Müer A, Overkamp T, Chumduri C, Jänicke RU, Gillissen B, Daniel PT.

Int J Cancer. 2013 Dec 1;133(11):2551-62. doi: 10.1002/ijc.28279. Epub 2013 Aug 1.

39.

NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia.

Terwey TH, Le Duc TM, Hemmati PG, le Coutre P, Nagy M, Martus P, Dörken B, Arnold R.

Ann Oncol. 2013 May;24(5):1363-70. doi: 10.1093/annonc/mds615. Epub 2012 Dec 17.

PMID:
23247660
40.

Mortality from Pandemic Influenza A (H1N1) in Iran.

Gouya MM, Nabavi M, Soroush M, Haghdoust AA, Ghalehee S, Hemmati P, Nasr Dadras M, Fallahzadeh MK, Lankarani KB.

Iran Red Crescent Med J. 2011 Oct;13(10):698-701. Epub 2011 Oct 1.

41.

Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.

Herzberg PY, Lee SJ, Heussner P, Mumm FH, Hilgendorf I, von Harsdorf S, Hemmati P, Rieger K, Greinix HT, Freund M, Holler E, Wolff D.

Bone Marrow Transplant. 2013 Jan;48(1):129-34. doi: 10.1038/bmt.2012.83. Epub 2012 May 21.

42.

Developing an educational scheme for undergraduate medical Curriculum: the unit of "infertility" as a sample.

Aflatoonian A, Baghianimoghadam B, Abdoli A, Partovi P, Hemmati P, Tabibnejad N, Harasym P.

J Med Life. 2012 Feb 22;5(1):16-20. Epub 2012 Mar 5. Review.

43.

p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.

Müer A, Overkamp T, Gillissen B, Richter A, Pretzsch T, Milojkovic A, Dörken B, Daniel PT, Hemmati P.

J Biol Chem. 2012 May 18;287(21):17343-52. doi: 10.1074/jbc.M111.314898. Epub 2012 Feb 21.

44.

A new classification for female infertility.

Aflatoonian A, Baghianimoghadam B, Partovi P, Abdoli A, Hemmati P, Tabibnejad N, Dehghani M.

Clin Exp Obstet Gynecol. 2011;38(4):379-81.

PMID:
22268279
45.

NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.

Terwey TH, Vega-Ruiz A, Hemmati PG, Martus P, Dietz E, le Coutre P, Massenkeil G, Dörken B, Arnold R.

Leukemia. 2012 Mar;26(3):536-42. doi: 10.1038/leu.2011.230. Epub 2011 Aug 26. No abstract available.

PMID:
21869841
46.

A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.

Hemmati PG, Terwey TH, le Coutre P, Vuong LG, Massenkeil G, Dörken B, Arnold R.

Eur J Haematol. 2011 Apr;86(4):305-16. doi: 10.1111/j.1600-0609.2011.01580.x.

PMID:
21265883
47.

Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.

Vuong LG, Hemmati PG, Neuburger S, Terwey TH, Vulliamy T, Dokal I, le Coutre P, Dörken B, Arnold R.

Acta Haematol. 2010;124(4):200-3. doi: 10.1159/000318721. Epub 2010 Nov 2.

PMID:
21042011
48.

Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.

Herzberg PY, Heussner P, Mumm FH, Horak M, Hilgendorf I, von Harsdorf S, Hemmati P, Rieger K, Greinix H, Freund M, Lee SJ, Holler E, Wolff D.

Biol Blood Marrow Transplant. 2010 Dec;16(12):1707-17. doi: 10.1016/j.bbmt.2010.05.018. Epub 2010 Jun 9.

49.

Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.

Hemmati PG, Müer A, Gillissen B, Overkamp T, Milojkovic A, Wendt J, Dörken B, Daniel PT.

J Mol Med (Berl). 2010 Jun;88(6):609-22. doi: 10.1007/s00109-010-0606-5. Epub 2010 Apr 25.

PMID:
20419447
50.

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.

Hemmati PG, Terwey TH, Massenkeil G, le Coutre P, Vuong LG, Neuburger S, Dörken B, Arnold R.

Int J Hematol. 2010 Apr;91(3):436-45. doi: 10.1007/s12185-010-0515-y. Epub 2010 Feb 25.

PMID:
20180052

Supplemental Content

Loading ...
Support Center